Corcept Therapeutics Incorporated (0I3Q.L) Stock Price
$70.31 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
6 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Corcept Therapeutics Incorporated, AI stock picks, stock alerts and much more.
0I3Q.L AI Stock Analysis
AI stock analysis for 0I3Q.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Corcept Therapeutics Incorporated (0I3Q.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Corcept Therapeutics Incorporated (0I3Q.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Corcept Therapeutics Incorporated (0I3Q.L), currently trading at $70.31, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0I3Q.L
-
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States.
-
Symbol
0I3Q.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
7.4B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$398.5 0.5% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$136.1 1.2% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$9.46 2.9% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$7.25 1.7% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$12.17 0.5% |
5 |
News
0I3Q.L Alternative Data
Web Traffic
Corcept Therapeutics Incorporated receives an estimated 24784 monthly visitors to corcept.com.
-
Web Traffic
24784
-
Change from Previous Month
38.8%
-
3 Month Change
32.7%
-
YoY Change
32.7%
Facebook Engagement
Corcept Therapeutics Incorporated has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Youtube Subscribers
Corcept Therapeutics Incorporated has 44 subscribers on its main Youtube channel, up by 2.3% over the last month.
-
Youtube Subscribers
44
-
Daily Change
0%
-
1 Month Change
2.3%
-
3 Month Change
18.9%
Job Postings
Corcept Therapeutics Incorporated has an estimated 74 open job postings, which is down -42.6% over the last month.
-
Job Postings
74
-
Daily Change
5.1%
-
1 Month Change
42.6%
-
3 Month Change
49.3%
-
YoY Change
49.3%
Reddit Mentions
Corcept Therapeutics Incorporated has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
59,921 are following Corcept Therapeutics Incorporated on LinkedIn, up by 2.3% over the last month.
-
LinkedIn Followers
59921
-
Daily Change
2.3%
-
1 Month Change
2.3%
-
3 Month Change
7.3%
-
YoY Change
7.3%
LinkedIn Employees
According to LinkedIn, Corcept Therapeutics Incorporated has 635 employees, up by 3.4% over the last month.
-
LinkedIn Employees
635
-
Daily Change
3.4%
-
1 Month Change
3.4%
-
3 Month Change
13.6%
-
YoY Change
13.6%
Business Outlook
According to employee reviews, the business outlook among employees at Corcept Therapeutics Incorporated is 52 out of 100 (neutral).
-
Business Outlook
52
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Corcept Therapeutics Incorporated was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0I3Q.L Financials
0I3Q.L Key Metrics
-
Total Revenue
$157.2M
-
Net Income
$20.3M
-
Earnings per Share
$0.19
-
Free cash flow
$5M
-
EBITDA
$3.4M
-
EBITDA Ratio
0.0217283
-
Total Assets
$846.5M
0I3Q.L 2-year Revenue & Income
0I3Q.L 2-year Free Cash Flow
0I3Q.L Technicals
0I3Q.L SMA
0I3Q.L RSI
FAQ
What's the current price of Corcept Therapeutics Incorporated (0I3Q.L) Stock?
The price of an Corcept Therapeutics Incorporated (0I3Q.L) share is $70.31.
What's the market cap of Corcept Therapeutics Incorporated?
The current market cap of Corcept Therapeutics Incorporated is 7.4B.
Should I buy or sell 0I3Q.L?
Corcept Therapeutics Incorporated shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Corcept Therapeutics Incorporated is better viewed as a hold or accumulate position while waiting for further developments.
Is Corcept Therapeutics Incorporated a good investment?
The current analysis of Corcept Therapeutics Incorporated's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Corcept Therapeutics Incorporated's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Corcept Therapeutics Incorporated (0I3Q.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Corcept Therapeutics Incorporated stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Corcept Therapeutics Incorporated (0I3Q.L) that investors often compare it to?
Corcept Therapeutics Incorporated (0I3Q.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Corcept Therapeutics Incorporated's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Corcept Therapeutics Incorporated's stock price to be around $72.93 in 2026. Starting from the current price of $70.31, this represents a 3.7% change in price, indicating a neutral outlook for the stock.
How to buy Corcept Therapeutics Incorporated (0I3Q.L) Stock?
Corcept Therapeutics Incorporated stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Corcept Therapeutics Incorporated shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.